Immunogenic compositions comprising progastrin and uses thereof
The present invention is drawn to immunotherapeutic methods to treat tumors/cancers that produce progastrin ectopically or are dependent on progastrin for their growth. Disclosed herein are immunogenic compositions comprising agents that target progastrin, agents that target the progastrin receptor, annexin II, or both. Such a composition may be administered in combination with chemotherapy or to an individual who had been previously subjected to chemotherapy or radiation therapy. The cancers that may be treated using such a composition may include but are not limited to colon cancer, breast cancer, lung cancer or pancreatic cancer..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Europäisches Patentamt - (2019) vom: 02. Juli Zur Gesamtaufnahme - year:2019 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
SINGH POMILA [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2019-07-02, Last update posted on www.tib.eu: 2022-06-12, Last updated: 2023-02-09 |
---|
Patentnummer: |
US10335470 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA006219535 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA006219535 | ||
003 | DE-627 | ||
005 | 20230504082723.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210531s2019 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA006219535 | ||
035 | |a (EPA)US10335470 | ||
035 | |a (EPA)39536641 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a SINGH POMILA |e verfasserin |4 aut | |
245 | 1 | 0 | |a Immunogenic compositions comprising progastrin and uses thereof |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2019-07-02, Last update posted on www.tib.eu: 2022-06-12, Last updated: 2023-02-09 | ||
520 | |a The present invention is drawn to immunotherapeutic methods to treat tumors/cancers that produce progastrin ectopically or are dependent on progastrin for their growth. Disclosed herein are immunogenic compositions comprising agents that target progastrin, agents that target the progastrin receptor, annexin II, or both. Such a composition may be administered in combination with chemotherapy or to an individual who had been previously subjected to chemotherapy or radiation therapy. The cancers that may be treated using such a composition may include but are not limited to colon cancer, breast cancer, lung cancer or pancreatic cancer. | ||
650 | 4 | |a che | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
650 | 4 | |a 615 | |
700 | 0 | |a SINGH GURPREET |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2019) vom: 02. Juli |
773 | 1 | 8 | |g year:2019 |g day:02 |g month:07 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/39536641/publication/US10335470A1?q=US10335470 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
912 | |a SSG-OLC-PHA | ||
936 | u | w | |j 2019 |b 02 |c 07 |
951 | |a AR | ||
952 | |j 2019 |b 02 |c 07 |